Harry D. Bear - Concepedia

Author

Harry D. Bear

Also Known As

Bear, Harry D., Bear, Harry Douglas, H Bear, H D Bear, H. Bear, H. D. Bear, H.D. Bear, Harry Bear, Harry D Bear, Harry D. Bear

333

Publications

17.5K

Citations

H-Index

129

Concepts

All Affiliations

Virginia Commonwealth University Virginia Commonwealth University Medical Center NSABP Foundation University of Pittsburgh Allegheny General Hospital

About

Harry D. Bear is an author at Virginia Commonwealth University specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	66	4.7K
2	Health Sciences	11	11	412
3	Public Health	3	3	102
4	Engineering	1	1	36
5	Nursing	1	1	36

Harry D. Bear

107

Publications

14.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Bernard Fisher, John Bryant, Norman Wolmark, Journal of Clinical Oncology	1998	2.2K
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Priya Rastogi, Stewart Anderson, Harry D. Bear, Journal of Clinical Oncology	2008	1.8K
The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Harry D. Bear, Stewart Anderson, Ann Brown, Journal of Clinical Oncology	2003	1.1K
Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Harry D. Bear, Stewart Anderson, Roy E. Smith, Journal of Clinical Oncology	2006	943
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Eleftherios P. Mamounas, Ann Brown, Stewart Anderson, Journal of Clinical Oncology	2005	545
Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04 Norman Wolmark, Howard E. Rockette, Eleftherios P. Mamounas, Journal of Clinical Oncology	1999	491
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer Harry D. Bear, Gong Tang, Priya Rastogi, New England Journal of Medicine	2012	464
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial Frank A. Vicini, Reena S. Cecchini, Julia White, The Lancet Surgical OncologyBreast OncologyRadiation TherapyMedicineBreast Cancer	2019	461
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Annals of Oncology Breast OncologyOverall SurvivalMedicinePathologyGermline Pathogenic Variants	2022	404
Current Landscape of Immunotherapy in Breast Cancer Sylvia Adams, Margaret E. Gatti‐Mays, Kevin Kalinsky, JAMA Oncology	2019	401

Page 1